FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089138 [Registered on: 19/06/2025] Trial Registered Prospectively
Last Modified On: 12/06/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   A PROSPECTIVE STUDY ON DIABETES, HYPERTENSON AND OBESITY RISK FACTORS’ AWARENESS IN GUWAHATI (METRO) CITY, AMONGST ATTENDANTS OF PATIENTS. BPOD AWARENESS STUDY. 
Scientific Title of Study   To evaluate the awareness of risk factors for diabetes, hypertension and obesity in Guwahati city, amongst attendants of patients. 
Trial Acronym  BPOD 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Bharat Bhushan Kukreja 
Designation  Principal Investigator 
Affiliation  Private Clinic 
Address  Room no.1, Ground floor, 69/2, S.R.C.B. Road, Fancy Bazar, Guwahati, 781001 (Assam)
Room no.1, Ground floor,69/2, S.R.C.B. Road, Fancy Bazar, Guwahati, 781001 (Assam)
Kamrup
ASSAM
781001
India 
Phone  9864093048  
Fax    
Email  bharatkukreja@hotmail.com  
 
Details of Contact Person
Scientific Query  
Name  Dr. Bharat Bhushan Kukreja 
Designation  Principal Investigator 
Affiliation  Private Clinic 
Address  Room no.1, Ground floor, Department of Medicine, 69/2, S.R.C.B. Road, Fancy Bazar, Guwahati, 781001 (Assam)
Room no.1, Ground floor, Department of Medicine, 69/2, S.R.C.B. Road, Fancy Bazar, Guwahati, 781001 (Assam)
Kamrup
ASSAM
781001
India 
Phone  9864093048  
Fax    
Email  bharatkukreja@hotmail.com  
 
Details of Contact Person
Public Query  
Name  Dr. Bharat Bhushan Kukreja 
Designation  Principal Investigator 
Affiliation  Private Clinic 
Address  Room no.1, Ground floor,69/2, Department of Medicine, S.R.C.B. Road, Fancy Bazar, Guwahati, 781001 (Assam)
Room no.1, Ground floor, Department of Medicine,69/2, S.R.C.B. Road, Fancy Bazar, Guwahati, 781001 (Assam)
Kamrup
ASSAM
781001
India 
Phone  9864093048  
Fax    
Email  bharatkukreja@hotmail.com  
 
Source of Monetary or Material Support  
Investigator initiated study.  
 
Primary Sponsor  
Name  Dr Bharat Bhushan Kukreja 
Address  Room no.1, Ground floor, Department of Medicine, 69/2, S.R.C.B. Road, Fancy Bazar, Guwahati, 781001 (Assam) 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bharat Bhushan Kukreja  Dr Bharats clinic  Dept of Medicine Room no.1, Ground floor,69/2, S.R.C.B. Road, Fancy Bazar, Guwahati, 781001 (Assam)
Kamrup
ASSAM 		 9864093048

bharatkukreja@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ECRC-HEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  -GENERAL POPULATION -AT RISK POPULATION 
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  - Adults aged 10 and above.
- Able to provide informed consent. 
 
ExclusionCriteria 
Details  - Attendant with behavior disorder or attention deficit.
- Person unwilling to provide informed consent. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The study will enable us to stratazise the usefulness and importance of primary
prevention of NCDs
 		 108 Weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Awareness Levels: Quantifying improvements in public knowledge & awareness
regarding diabetes, hypertension, & overweight. 		 108 weeks 
 
Target Sample Size   Total Sample Size="1000"
Sample Size from India="1000" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [bharatkukreja@hotmail.com].

  6. For how long will this data be available start date provided 02-01-1970 and end date provided 02-01-1970?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   The recent findings from ICMR study Indiab on NCDs (Anjana 2011et al.) showing diabetes 11.4%, prediabetes 15.3%, hypertension 35.5%, generalized obesity 28.6% in urban India, prompted us to design a questionnaire based study amongst the attendants of the patients who comes for treatment of these clinical conditions. NCDs being asymptomatic in more than 50% of the population, it is pertinent that awareness and preventive measures be taken early to highlight the factors which would help health care providers in defining preventive strategies for primary prevention 
Close